ESMO 2023: A Wealth of New Data Across Cancer Types

The march of immunotherapy into a wider range of malignancies, as well as the smarter use of chemotherapy and novel targeted drugs, will be among the key highlights at the ESMO Congress 2023.

Related Keywords

Madrid ,Spain ,Angela Lamarca ,European Society For Medical Oncology ,Fundacion Jimenez Diaz University Hospital ,European Society ,Medical Oncology ,Medscape Medical ,Proffered Paper ,Biologic Therapy ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,Medical Conferences ,Professional Societies ,Small Molecule Inhibitor ,Monoclonal Antibody ,Etuximab ,Ituximab ,Clinical Research ,Clinical Trials ,Linical Studies ,Cancer ,Alignant Neoplasia ,Arcinoma ,Cervical Cancer ,Alignant Cervix Neoplasm ,Non Small Cell Lung Cancer ,Nsclc ,Targeted Therapy ,Endometrial Carcinoma ,Chemotherapy ,Thyroid C ,